Patents Assigned to Aveve, N.V.
  • Patent number: 7261888
    Abstract: The present invention relates to the use of triglycerides (TG) containing medium chain fatty acids (C4 to C12), combined with exogenous lipolytic enzymes (esterases or lipases) as a feed supplement for animals in order to prevent and/or alleviate the problems which are frequently met at this moment. This results in a marked improvement of the growth performances without the use of the classical, but contested, feed additives.
    Type: Grant
    Filed: June 6, 2000
    Date of Patent: August 28, 2007
    Assignees: Aveve N.V., Vitamex N.V.
    Inventors: Jaak Decuypere, Noël Dierick
  • Patent number: 6197542
    Abstract: The invention relates to genetic manipulations of eukaryotic organisms, with recombinant DNA comprising RNA virus derived sequences for protecting such organisms against RNA viruses or enabling inducible or tissue-specific production of foreign proteins/peptides or RNAs. One embodiment of the recombinant DNA according to the invention comprises recombinant DNA, comprising two, 12-1250 base pair long, inverted repeat nucleotide sequences with therebetween at least one nucleotide sequence which is derived from RNA virus which for its replication is dependent upon a viral RNA/RNA polymerase, said RNA virus derived sequence comprising at least cis elements for replication but no gene that codes for viral RNA/RNA polymerase and no gene that codes for viral coat protein. The invention also relates to eukaryotic or prokaryotic cells or organisms which incorporate the recombinant DNA according to the invention.
    Type: Grant
    Filed: July 28, 1997
    Date of Patent: March 6, 2001
    Assignee: Aveve, N.V.
    Inventors: Eddie Van Haute, Paul Ameloot, Jean De Lafonteyne, Walter Fiers
  • Patent number: 6093554
    Abstract: The invention relates to genetic manipulations of eukaryotic organisms, with recombinant DNA comprising RNA virus derived sequences for protecting such organisms against RNA viruses or enabling inducible or tissue-specific production of foreign proteins/peptides or RNAs. One embodiment of the recombinant DNA according to the invention comprises recombinant DNA, comprising two, 12-250 base pair long, inverted repeat nucleotide sequences with therebetween at least one nucleotide sequence which is derived from RNA virus which for its replication is dependent upon a viral RNA/RNA polymerase, said RNA virus derived sequence comprising at least cis elements for replication but no gene that codes for viral RNA/RNA polymerase and no gene that codes for viral coat protein. The invention also relates to eukaryotic or prokaryotic cells or organisms which incorporate the recombinant DNA according to the invention.
    Type: Grant
    Filed: January 21, 1999
    Date of Patent: July 25, 2000
    Assignees: Aveve N.V., Clovis Matton
    Inventors: Eddie Van Haute, Paul Ameloot, Jean De Lafonteyne, Walter Fiers